Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号

Headquarter Address: 8888 Lvyou Road, Jinan, Shandong 250104, CHINA Powered by www.300.cn

Qilu Launches Generic Aloxi® Injection in the US

Qilu Launches Generic Aloxi® Injection in the US

Release time:
2018-09-19
Qilu Antibiotics passed US FDA inspection with no 483 observation

Qilu Antibiotics passed US FDA inspection with no 483 observation

Release time:
2018-08-16
Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA

Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA

Release time:
2018-08-13
Qilu ranked top 10 of the Chinese Pharmaceutical Industry in 4 consecutive times

Qilu ranked top 10 of the Chinese Pharmaceutical Industry in 4 consecutive times

Release time:
2018-08-04
Qilu honored as the top 20 leading enterprise of internationalization

Qilu honored as the top 20 leading enterprise of internationalization

Release time:
2018-06-21
Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection

Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection

Release time:
2018-04-14
Qilu King-Phar successfully passes the US FDA inspection with no 483 observations

Qilu King-Phar successfully passes the US FDA inspection with no 483 observations

Release time:
2017-04-19
Qilu Synva passed FDA inspection with Zero observation in June 2016

Qilu Synva passed FDA inspection with Zero observation in June 2016

Release time:
2016-06-28
Qilu Pharma passed EDQM inspection successfully

Qilu Pharma passed EDQM inspection successfully

Release time:
2015-12-07
One lyophilized FDF was approved in UK

One lyophilized FDF was approved in UK

Release time:
2015-12-07